Wednesday, August 19, 2015

Pivotal Phase II study showed Roche’s investigational immunotherapy atezolizumab shrank tumours in people with a specific type of lung cancer

… advanced or metastatic non-small cell lung cancer (NSCLC) whose disease expressed PD-L1 … ) and safety. About non-small cell lung cancer Lung cancer is the leading cause of … all cases. About Roche in lung cancer Lung cancer is a major area of … for every person diagnosed with lung cancer. We currently have three approved …

No comments:

Post a Comment